HARMONIE PHARMA
The computed 12-month bankruptcy probability of HARMONIE PHARMA is 1.3% (low). The 2024 annual accounts show equity of €297k and a net result of €-230k. Equity is growing by ~11% per year across the filed fiscal years. Its solvency ranks better than 94% of 6692 sector peers (fiscal year 2024). The company has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €297k |
| Net result | €-230k |
| Better than sector | 94% |
| Active | 28 yrs |
Strong profile, led by solvency.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 82.9% | 20.4% | |
| Net result | €-230k | €4k | |
| Equity | €297k | €16k | |
| Gross operating margin | €-59k | €24k | |
| Staff costs | €63k | €33k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-128k |
| Net profit | €-230k |
| Cash flow | €-222k |
| Staff costs | €63k |
| Income taxes | €96k |
| Dividends | - |
| Total assets | €358k |
| Equity | €297k |
| Debt | €61k |
| of which ≤ 1y | €61k |
| of which > 1y | €0 |
| Working capital | €268k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 5.38 |
| Quick ratio | 3.74 |
| Working capital ratio | 74.8% |
| Solvency | 82.9% |
| Debt / equity | 0.21 |
| Long-term debt ratio | 0.00 |
| Interest coverage | -58.40 |
| Gross margin | - |
| Net margin | - |
| ROA | -64.2% |
| ROE | -77.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €358k |
| Fixed assets | 21/28 | €29k |
| Tangible fixed assets | 22/27 | €26k |
| Financial fixed assets | 28 | €4k |
| Current assets | 29/58 | €329k |
| Stocks & contracts in progress | 3 | €101k |
| Amounts receivable within one year | 40/41 | €63k |
| Cash & bank | 54/58 | €59k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €358k |
| Equity | 10/15 | €297k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €2k |
| Accumulated profits (losses) | 14 | €277k |
| Amounts payable | 17/49 | €61k |
| Amounts payable after one year | 17 | €0 |
| Amounts payable within one year | 42/48 | €61k |
| Trade debts payable within one year | 44 | €54k |
| Income statement | ||
| Gross operating margin | 9900 | €-59k |
| Operating result | 9901 | €-135k |
| Financial income | 75 | €3k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €-134k |
| Income taxes | 67/77 | €96k |
| Net result for the period | 9904 | €-230k |
| Result to be appropriated | 9905 | €-230k |
-
GROUPE TETE PHARMACEUTICALLegal entityDirector· perm. rep.: Tete KwassiganState Gazette act 26050304 (17-04-2026)Current17-04-2026 → present
Historic, not recently confirmed (2)
-
Novesta bvbaLegal entityManager· perm. rep.: Him OMARState Gazette act 17084344 (16-06-2017)Not recently confirmedlast confirmed in an act from 2017
-
Not recently confirmedlast confirmed in an act from 2016
Former directors (4)
-
Former18-07-2016 → 01-06-2017
2 events
- 01-06-2017 Resigned· Manager
- 18-07-2016 Mandate renewed· Manager
-
Former- → 30-06-2016
-
Former31-05-2016 → 30-06-2016
2 events
- 30-06-2016 Resigned· Manager
- 31-05-2016 Appointed· Manager
-
Former31-05-2016 → 30-06-2016
2 events
- 30-06-2016 Resigned· Manager
- 31-05-2016 Appointed· Manager
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 30-10-1997 |
| Status | Active |
| Postal code | 1000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21812N0980/00D000 | Brussels | 3,679 m² | 1 · 979 m² | 25.4 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
20-05-2026 General meeting · Name change · Statute amendment · Power of attorney
- Filing: 2026-05-18 · PHARMA YSER
- General meeting: 2026-05-08 · PHARMA YSER
- Name change: HARMONIE PHARMA · PHARMA YSER
- Statute amendment: article 1 · PHARMA YSER
- Power of attorney: faire le nécessaire pour la coordination des statuts · PHARMA YSER
- Notarial deed: 2026-05-08 · PHARMA YSER
- Publication: 2026-05-20
- Act object: BENAMING
Technical details
{
"facts": [
{
"type": "filing",
"quote": "Neergelegd 18-05-2026",
"value": "2026-05-18",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Par devant le Notaire Jonathan Flameng, de r\u00E9sidence \u00E0 Ch\u00E2telet, en date du 8 mai 2026, S\u0027est r\u00E9unie l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u0022PHARMA YSER\u0022",
"value": "2026-05-08",
"object": null,
"subject": "e1"
},
{
"type": "name_change",
"quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de modifier la d\u00E9nomination actuelle en \u0022HARMONIE PHARMA\u0022.",
"value": "HARMONIE PHARMA",
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de modifier l\u0027article 1 des statuts pour l\u0027adapter \u00E0 la pr\u00E9sente modification de la d\u00E9nomination.",
"value": "article 1",
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u2019assembl\u00E9e donne tous pouvoirs \u00E0 l\u2019administrateur pour faire le n\u00E9cessaire pour la coordination des statuts.",
"value": "faire le n\u00E9cessaire pour la coordination des statuts",
"object": "e5",
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "Par devant le Notaire Jonathan Flameng, de r\u00E9sidence \u00E0 Ch\u00E2telet, en date du 8 mai 2026",
"value": "2026-05-08",
"object": "e2",
"subject": "e1"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 20/05/2026",
"value": "2026-05-20",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Onderwerp akte : BENAMING",
"value": "BENAMING",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 3459,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0461.800.766",
"kind": "company",
"name": "PHARMA YSER",
"attrs": {
"seat": "Lakensestraat 129, 1000 Brussel",
"new_name": "HARMONIE PHARMA",
"legal_form": "Besloten Vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Jonathan Flameng",
"attrs": {
"role": "Notaire"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Kwassigan (dit \u00AB Aim\u00E9 \u00BB) TETE",
"attrs": {
"role": "pr\u00E9sident"
}
},
{
"id": "e4",
"kbo": "0542.600.182",
"kind": "company",
"name": "Groupe Tete Pharmaceutical SRL",
"attrs": {
"role": "actionnaire unique",
"seat": "1400 Nivelles, rue de l\u0027\u00E9v\u00EAch\u00E9 8"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "TETE Kwassigan Tsonyuido",
"attrs": {
"role": "administrateur",
"address": "rue Saint-George 33 \u00E0 1400 Nivelles"
}
}
]
}17-04-2026 Act object · General meeting · Officer resignation · Officer discharge
- Filing: 2026-04-10 · PHARMA YSER
- Publication: 2026-04-17 · PHARMA YSER
- Act object: Ontslag - Benoeming · PHARMA YSER
- General meeting: 2026-04-01 · PHARMA YSER
- Officer resignation: role: bestuurder · Crown Consultancy BV
- Officer resignation: role: permanent vertegenwoordiger · Crown Consultancy BV
- Officer resignation: role: permanent vertegenwoordiger · Him Omar
- Officer discharge · Him Omar
- Officer appointment: role: bestuurder · GROUPE TETE PHARMACEUTICAL BV
- Permanent representative: role: Vaste Vertegenwoordiger · Tete Kwassigan
- Board meeting · PHARMA YSER
- Officer appointment: role: bestuurder · GROUPE TETE PHARMACEUTICAL BV
- Power of attorney: purpose: afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank · MBM Groupe BV
- Power of attorney: purpose: afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank · Thierry Graulich
- Power of attorney: purpose: afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank · Christophe Dereume
- Power of attorney: purpose: afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank · Isabelle De Roose
Technical details
{
"facts": [
{
"type": "filing",
"quote": "neergelegd/ontvangen op 10 APR. 2026",
"value": "2026-04-10",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 17/04/2026",
"value": "2026-04-17",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Onderwerp akte: Ontslag - Benoeming",
"value": "Ontslag - Benoeming",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "De notulen van de buitengewone algemene vergadering van Pharma Yser BV, gehouden op 1 april 2026",
"value": "2026-04-01",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "De Algemene Vergadering aanvaardt het ontslag van Crown Consultancy BV (BE0749.592.244) ... als bestuurder",
"value": {
"role": "bestuurder"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_resignation",
"quote": "De Algemene Vergadering aanvaardt het ontslag van Crown Consultancy BV (BE0749.592.244) ... als permanent vertegenwoordiger",
"value": {
"role": "permanent vertegenwoordiger"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_resignation",
"quote": "De Algemene Vergadering aanvaardt het ontslag van Crown Consultancy BV (BE0749.592.244) ... als permanent vertegenwoordiger, de heer Him Omar",
"value": {
"role": "permanent vertegenwoordiger"
},
"object": "e1",
"subject": "e4"
},
{
"type": "officer_discharge",
"quote": "De Algemene Vergadering aanvaardt unaniem zijn ontslag en verleent hem voorlopige kwijting voor het beheer tot die datum",
"value": null,
"object": "e1",
"subject": "e4"
},
{
"type": "officer_appointment",
"quote": "De Algemene Vergadering benoemt GROUPE TETE PHARMACEUTICAL BV (KBO 0542.600.182) ... tot bestuurder.",
"value": {
"role": "bestuurder"
},
"object": "e1",
"subject": "e5"
},
{
"type": "permanent_representative",
"quote": "De heer Tete Kwassigan ... wordt hierbij, v\u00F3\u00F3r de ondertekening van dit document, benoemd tot Vaste Vertegenwoordiger van GROUPE TETE PHARMACEUTICAL BV om de bovengenoemde functies uit te oefenen.",
"value": {
"role": "Vaste Vertegenwoordiger"
},
"object": "e5",
"subject": "e6"
},
{
"type": "board_meeting",
"quote": "De nieuw samengestelde Raad van Bestuur vergaderde vervolgens.",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "officer_appointment",
"quote": "GROUPE TETE PHARMACEUTICAL BV (BE0542.600.182) ... wordt benoemd tot bestuurder.",
"value": {
"role": "bestuurder"
},
"object": "e1",
"subject": "e5"
},
{
"type": "power_of_attorney",
"quote": "De vergadering machtigt MBM Groupe BV ... voor het afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank.",
"value": {
"purpose": "afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank"
},
"object": "e1",
"subject": "e7"
},
{
"type": "power_of_attorney",
"quote": "De vergadering machtigt MBM Groupe BV ... vertegenwoordigd door de heer Thierry Graulich en/of de heer Christophe Dereume en/of mevrouw Isabelle De Roose, voor het afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank.",
"value": {
"purpose": "afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank"
},
"object": "e1",
"subject": "e8"
},
{
"type": "power_of_attorney",
"quote": "De vergadering machtigt MBM Groupe BV ... vertegenwoordigd door de heer Thierry Graulich en/of de heer Christophe Dereume en/of mevrouw Isabelle De Roose, voor het afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank.",
"value": {
"purpose": "afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank"
},
"object": "e1",
"subject": "e9"
},
{
"type": "power_of_attorney",
"quote": "De vergadering machtigt MBM Groupe BV ... vertegenwoordigd door de heer Thierry Graulich en/of de heer Christophe Dereume en/of mevrouw Isabelle De Roose, voor het afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank.",
"value": {
"purpose": "afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank"
},
"object": "e1",
"subject": "e10"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 2448,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0461.800.766",
"kind": "company",
"name": "PHARMA YSER",
"attrs": {
"seat": "Lakensestraat 129 - 1000 Brussel",
"legal_form": "Besloten vennootschap"
}
},
{
"id": "e2",
"kbo": "0749.592.244",
"kind": "company",
"name": "Crown Consultancy BV",
"attrs": {
"seat": "Maria van Hongarijselaan 22, 1083 Ganshoren"
}
},
{
"id": "e3",
"kbo": "0568.541.447",
"kind": "company",
"name": "Novesta BV",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Him Omar",
"attrs": {}
},
{
"id": "e5",
"kbo": "0542.600.182",
"kind": "company",
"name": "GROUPE TETE PHARMACEUTICAL BV",
"attrs": {
"seat": "Rue de l\u0027Evech\u00E9 8, 1400 Nivelles"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Tete Kwassigan",
"attrs": {}
},
{
"id": "e7",
"kbo": "0542.637.202",
"kind": "company",
"name": "MBM Groupe BV",
"attrs": {
"seat": "Avenue Tedesco 7, 1160 Oudergem, Belgi\u00EB"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Thierry Graulich",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Christophe Dereume",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Isabelle De Roose",
"attrs": {}
}
]
}12-07-2024 Him Omar reappointed as director
- Him Omar, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Him Omar",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0568541447",
"name": "Novesta",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de mettre fin \u00E0 la fonction du g\u00E9rant actuel, mentionn\u00E9 ci-apr\u00E8s, et proc\u00E8de imm\u00E9diatement au renouvellement de sa nomination comme administrateur non statutaire pour une dur\u00E9e illimit\u00E9e : - La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022Novesta\u0022, dont le si\u00E8ge social est \u00E9tabli \u00E0 "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0461.800.766",
"name_full": "BELLIPHARMA YSER",
"legal_form": "BVBA"
}
}16-06-2017 1 director appointed, 1 resigning
- Him OMAR, Zaakvoerder
- Shilan OMAR, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Shilan OMAR",
"address": null,
"birth_date": null
},
"effective_date": "2017-06-01",
"evidence_quote": "Te ontslaan als zaakvoerder en dit met ingang vanaf 01/06/2017: mevrouw Shilan OMAR, gedomicilieerd te Jetselaan 58- 1081 Koekelberg."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Him OMAR",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Novesta bvba",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2017-06-01",
"evidence_quote": "Te benoemen tot zaakvoerder en dit met ingang vanaf 01/06/2017 en voor onbepaaide duur: Novesta bvba, met zetel te Wereldtentoonstellingslaan 7/B10, 1083 Brussel, vertegenwoordigd door de heer Him OMAR als vaste vertegenwoordiger van Novesta bvba."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0461.800.766",
"name_full": "BELLIPHARMA YSER",
"legal_form": "BVBA"
}
}21-09-2016 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": true,
"seat_change": false,
"object_change": false,
"effective_date": "2016-09-02",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0461.800.766",
"name_full": "PHARMACIE MALFAIT-BOTBOL",
"legal_form": "BVBA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}18-07-2016 1 director appointed, 3 resigning, 1 reappointed
- Lazgin OTHMAN, Zaakvoerder
- Him OMAR, Zaakvoerder
- Isolde BLONDELLE, Zaakvoerder
- Noshin OMAR, Zaakvoerder
- Shilan OMAR, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Him OMAR",
"address": null,
"birth_date": null
},
"effective_date": "2016-06-30",
"evidence_quote": "De algemene vergadering aanvaardt het ontslag van Meneer Him OMAR, gedomicilieerd te Wereldtentoonstellingslaan 7/B10 - 1083 Ganshoren, als zaakvoerder en dit met onmiddelijke ingang.",
"discharge_granted": true
},
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Isolde BLONDELLE",
"address": null,
"birth_date": null
},
"effective_date": "2016-06-30",
"evidence_quote": "De algemene vergadering aanvaardt het ontslag van Mevrouw Isolde BLONDELLE, gedomicilleerd te Wereldtentoonstellingslaan 7/B10-1083 Ganshoren, als zaakvoerder en dit met onmiddelijke ingang.",
"discharge_granted": true
},
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Noshin OMAR",
"address": null,
"birth_date": null
},
"effective_date": "2016-06-30",
"evidence_quote": "De algemene vergadering aanvaardt het ontslag van Meneer Noshin OMAR, gedomicilieerd te Gouden Leeuwstraat 17-9300 Aalst, als zaakvoerder en dit met onmiddelijke ingang.",
"discharge_granted": true
},
{
"kind": "director_renew",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Shilan OMAR",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering hernieuwt het mandaat van Mevrouw Shilan OMAR, gedomicilieerd te Jetselaan 58-1081 Koekelberg, als zaakvoerder en dit voor onbepaalde duur."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Lazgin OTHMAN",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering benoemt Meneer Lazgin OTHMAN, gedomicilieerd te Jetselaan 58 - 1081 Koekelberg, tot zaakvoerder en dit voor onbepaalde duur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0461.800.766",
"name_full": "PHARMACIE MALFAIT-BOTBOL",
"legal_form": "BVBA"
}
}31-05-2016 2 directors appointed
- Isolde BLONDELLE, Zaakvoerder
- Noshin OMAR, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Isolde BLONDELLE",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering benoemt Mevrouw Isolde BLONDELLE, gedomicilieerd Wereldtentoonstellingslaan 7/B10 te 1083 Ganshoren, tot zaakvoerder en dit voor een onbepaalde duur."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Noshin OMAR",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering benoemt Meneer Noshin OMAR, gedomicilieerd te Gouden Leeuwstraat 17, 9300 Aalst, tot zaakvoerder en dit voor een onbepaalde duur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0461.800.766",
"name_full": "PHARMACIE MALFAIT-BOTBOL",
"legal_form": "BVBA"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | HARMONIE PHARMA |
| Legal nameNL | PHARMA YSER |